Myocardial Hemodynamics, Physiology, and Perfusion With an Axial Flow Left Ventricular Assist Device in the Calf
Authors:
- Kazuhiro EyaKEKazuhiro Eya
- Hyun Keun CheeHCHyun Keun Chee
- Jeff L. CongerJCJeff L. Conger
- Natalie K. BrunoNBNatalie K. Bruno
- O. H. FrazierOFO. H. Frazier
- Kamuran A. KadipasaogluKKKamuran A. Kadipasaoglu
- 1 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 50 (1) , 47-53
Abstract
The Jarvik 2000 axial flow left ventricular assist device (LVAD) is used clinically as a bridge to transplantation or as destination therapy in end-stage heart disease. The effect of the pump’s continuous flow output on myocardial and end-organ blood flow has not been studied experimentally. To address this, the Jarvik 2000 pump was implanted in eight calves and then operated at speeds ranging from 8,000 to 12,000 rpm. Micromanometry, echocardiography, and blood oxygenation measurements were used to assess changes in hemodynamics, cardiac dimensions, and myocardial metabolism, respectively, at different speeds as compared with baseline (pump off, 0 rpm) in this experimental model. Microsphere studies were performed to assess the effects on heart, kidney, and brain perfusion at different speeds. The Jarvik 2000 pump unloaded the left ventricle and reduced end-diastolic pressures and left ventricular dimensions, particularly at higher pump speeds. The ratio of myocardial oxygen consumption to coronary blood flow and the ratio of subendocardial to subepicardial blood flow remained constant. Optimal adjustment of pump speed and volume status allowed opening of the aortic valve and contribution of the native left ventricle to cardiac output, even at the maximum pump speed. Neither brain nor kidney microcirculation was adversely affected at any pump speed. We conclude that the Jarvik 2000 pump adequately unloads the left ventricle without compromising myocardial metabolism or end-organ perfusion.Keywords
This publication has 25 references indexed in Scilit:
- End-organ function during chronic nonpulsatile circulationThe Annals of Thoracic Surgery, 2002
- Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist SystemCirculation, 2002
- Initial Clinical Experience With the Jarvik 2000 Implantable Axial-Flow Left Ventricular Assist SystemCirculation, 2002
- Major Organ Function Under Mechanical Support: Comparative Studies of Pulsatile and Nonpulsatile CirculationArtificial Organs, 1999
- Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated CardiomyopathyCirculation, 1997
- Development of an Implantable Ventricular Assist SystemThe Annals of Thoracic Surgery, 1997
- Determination of tin in human blood serum by radiochemical neutron activation analysisAnalytical Chemistry, 1991
- Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3.Circulation, 1989
- Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography.Circulation, 1980
- Concentration of 24 Trace Elements in Human Heart Tissue Determined by Neutron Activation AnalysisScandinavian Journal of Clinical and Laboratory Investigation, 1965